Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada.
Peter Munk Cardiac Centre of University Health Network, Toronto, Ontario, Canada.
J Am Soc Echocardiogr. 2020 Jul;33(7):802-811.e6. doi: 10.1016/j.echo.2019.12.016. Epub 2020 Mar 9.
Although echocardiography is widely used to measure left ventricular ejection fraction (LVEF), its prognostic value has not been demonstrated in a broad range of patients including those acutely hospitalized for cardiac or noncardiac causes. We determined whether greater degrees of left ventricular systolic dysfunction were associated with progressively increasing risks of death or cardiovascular hospitalizations among patients in hospital or outpatient settings.
A total of 27,323 patients with LVEF measured and 19,445 matched controls were followed for 223,034 person-years. Outcomes of total mortality, cardiovascular death, cardiovascular hospitalizations, and heart failure hospitalizations were examined using cause-specific hazard competing-risks analysis.
In the study cohort (median age, 68 [interquartile range, 58-77], 14,828 women [31.7%]), the hazard ratios (95% CI) for all-cause death were 1.67 (1.57-1.77), 1.30 (1.24-1.36), and 1.17 (1.11-1.23) when LVEF was <25%, 25%-35%, or 36%-45% compared with LVEF 46%-55% (all P < .001). Rates of cardiovascular death were similarly higher with lower LVEF. The hazard ratios for cardiovascular hospitalization were 1.35 (1.27-1.42), 1.21 (1.16-1.27), and 1.13 (1.07-1.18) for LVEFs <25%, 25%-35%, and 36%-45%, respectively (all P < .001). The rate of heart failure hospitalizations was amplified, with hazard ratios of 1.71 (1.59-1.85), 1.39 (1.31-1.48), and 1.21 (1.13-1.29) for LVEFs <25%, 25%-35%, or 36%-45% (all P < .001). The rate of mortality and hospitalizations increased comparably with greater reductions in LVEF during both inpatient cardiac or noncardiac admissions (P < .001).
Quantitative echocardiographic LVEF stratified the risk of death and hospitalization in a wide range of clinical settings, including during noncardiac admissions.
尽管超声心动图被广泛用于测量左心室射血分数(LVEF),但其在包括因心脏或非心脏原因急性住院的广泛患者中的预后价值尚未得到证实。我们确定了左心室收缩功能障碍的严重程度是否与住院或门诊患者的死亡或心血管住院风险的逐渐增加相关。
共有 27323 名患者进行了 LVEF 测量,19445 名匹配的对照者随访了 223034 人年。使用特定于原因的风险竞争风险分析来检查总死亡率、心血管死亡、心血管住院和心力衰竭住院的结果。
在研究队列中(中位年龄 68 [四分位距 58-77],14828 名女性[31.7%]),当 LVEF <25%、25%-35%或 36%-45%时,全因死亡的危险比(95%CI)分别为 1.67(1.57-1.77)、1.30(1.24-1.36)和 1.17(1.11-1.23)与 LVEF 46%-55%相比(均 P<.001)。较低的 LVEF 与更高的心血管死亡率相关。LVEF <25%、25%-35%和 36%-45%时,心血管住院的危险比分别为 1.35(1.27-1.42)、1.21(1.16-1.27)和 1.13(1.07-1.18)(均 P<.001)。心力衰竭住院的发生率更高,危险比分别为 1.71(1.59-1.85)、1.39(1.31-1.48)和 1.21(1.13-1.29)对于 LVEF <25%、25%-35%或 36%-45%(均 P<.001)。在住院心脏或非心脏入院期间(P<.001),随着 LVEF 的降低,死亡率和住院率的增加相当。
定量超声心动图 LVEF 分层了广泛临床环境中的死亡和住院风险,包括非心脏入院期间。